Device Trial Radar · NCT02864043
Barrett's Dysplasia Detection Pilot Trial Using the NvisionVLE® Imaging System
Last checked: Nov 20, 2026Latest source record: Mar 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Actual
Start
Sep 2016
Primary completion
Jun 1, 2020
Study completion Jun 1, 2020
Sponsor
- Lead sponsor
- NinePoint MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The NvisionVLE® Dysplasia Detection Pilot Study is a prospective, non-randomized trial for participants who have a prior biopsy-confirmed diagnosis of BE with dysplasia and are scheduled to have an endoscopic evaluation of your esophagus for BE surveillance by a standard procedure called EGD (esophagogastroduodenoscopy) as well as an imaging procedure called VLE (volumetric laser endomicroscopy).
Conditions
- Barrett's Esophagus
Interventions
NvisionVLE with Real Time TargetingDevice
Physician will complete a VLE scan of the esophagus and target areas of interest using the VLE optical marking probe
esophagogastroduodenoscopy (EGD)Procedure
Standard of care EGD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance of manually identified VLE features in predicting biopsy defined dysplasiaTime frame: Up to 2 years post data collection
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
UC Irvine Medical Center
Irvine, California
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.